Delta Shock Index in Predicting Massive Transfusion
The Relationship of Delta Shock Index With the Requirement of Blood Transfusion and Clinical Outcome of Adult Trauma Patients
Background: To determine the performance of delta shock index (ΔSI), a change in shock index (SI) upon arrival at the emergency room (ER) from that in the field in predicting the need for massive transfusion (MT) among adult trauma patients with stable blood pressure.
Methods: This study included data from all trauma patients aged 20 years and above who were hospitalized from January 1, 2009 to December 31, 2016 and was obtained from the registered trauma database of the hospital. Only patients who were transferred by emergency medical service from the accident site with a systolic blood pressure ≥ 90 mm Hg at the ER were included in this study. The 7,957 enrolled trauma patients were divided into 2 groups, those who had received blood transfusion ≥ 10 U (MT, n = 82) and those who had not (non-MT, n = 7,875). The odds ratios with 95% confidence intervals for associated patient conditions and the odds of need for MT by a given ΔSI were measured. The plot of specific receiver operating characteristic (ROC) curves was used to evaluate the best cutoff point that could predict the patient's probability of receiving MT.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Kaohsiung, Taiwan, 83301
- Kaohsiung Chang Gung Memorial Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Patients who were transferred by emergency medical service (EMS) from the field of accident and had a stable blood pressure (SBP ≥ 90 mmHg) at the ER were included
Exclusion Criteria:
- Patients who were transferred from other hospitals or arrived by private vehicles.
- Patients who had incomplete data
- Patients who had an unstable blood pressure (SBP < 90 mmHg) upon arrival at the ER were also excluded
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Case-Control
- Tidsperspektiver: Tilbagevirkende kraft
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Trauma patients' SBP ≥ 90 mm Hg with EMS
Only patients who were transferred by emergency medical service from the accident site with a systolic blood pressure ≥ 90 mm Hg at the ER were included in this study.
The enrolled trauma patients divided into 2 groups, those who had received blood transfusion ≥ 10 U (massive transfusion) and those who had not (non-massive transfusion).
|
Trauma patients who had received blood transfusion≥10 U
Trauma patients who had received blood transfusion<10 U
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
dødelighed på hospitalet
Tidsramme: op til 5 måneder
|
At måle patienternes resultat.
|
op til 5 måneder
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CMRPG8G1301
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Massive transfusion
-
Kepler University HospitalAfsluttetTransfusionsafhængig anæmiØstrig
-
Taichung Veterans General HospitalAfsluttetNasopharyngeal karcinompatienter behandlet med helbredende strålebehandlingTaiwan
-
University of FloridaAfsluttet
-
Sunnybrook Health Sciences CentreCanadian Blood Services; National Blood Foundation; Canadian Department of...AfsluttetHæmoragisk chok | Traume koagulopatiCanada
-
Chang Gung Memorial HospitalAfsluttetSygdomsprogression | Gastrointestinale stromale tumorer | MetastaseTaiwan
-
University of SienaFondazione Policlinico Universitario Agostino Gemelli IRCCS; Istituti Ospitalieri... og andre samarbejdspartnereRekruttering
-
Zeliha AlicikusRekrutteringTrauma | Massiv blodtransfusion; Trombocytopeni | TromboembolusForenede Stater
-
Brooke Army Medical CenterCongressionally Directed Medical Research Programs; The Metis Foundation; University of Colorado HealthRekrutteringBivirkninger ved terapeutisk brug af andre og uspecificerede midler, der påvirker blodbestanddeleForenede Stater
-
Assistance Publique - Hôpitaux de ParisAfsluttetMyokardieinfarkt | Anæmi | BlodtransfusionSpanien, Frankrig
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityTrukket tilbageAnæmi | Nekrotiserende enterocolitis | Transfusion af røde blodlegemer (RBC).Kina